advocacy

These are posts to help you advocate for 7-oh

advocacy, media outreach, springfling

New York Senate Bill 8925S8925A / A9156 — 7-Hydroxymitragynine RestrictionsNew York Senate Bill 8925

Priority targets Name Role Phone Email J. Gary Pretlow Ways & Means Chair 518-455-5291 PretloJ@nyassembly.gov Carl Heastie Assembly Speaker / Rules Chair — Speaker@nyassembly.gov Phil Steck A9156B Sponsor 518-455-5931 SteckP@nyassembly.gov Mary Beth Walsh Co-sponsor / Ways & Means 518-455-5772 walshm@nyassembly.gov Philip Palmesano Ranking Minority, Ways & Means 518-455-5791 palmesanop@nyassembly.gov Edward Ra Assembly Minority Leader 518-455-3751 rae@nyassembly.gov Ways & Means Committee members Name Phone Email Michael Benedetto 518-455-5296 benedettom@nyassembly.gov Rodneyse Bichotte Hermelyn 518-455-5385 bichotter@nyassembly.gov Ken Blankenbush 518-455-5797 blankenbushk@nyassembly.gov Edward C. Braunstein 518-455-5425 braunsteine@nyassembly.gov Harry B. Bronson 518-455-4527 bronsonh@nyassembly.gov William Colton 518-455-5828 ColtonW@nyassembly.gov Vivian E. Cook 518-455-4203 CookV@nyassembly.gov Catalina Cruz 518-455-4567 cruzc@nyassembly.gov Joe DeStefano 518-455-4901 destefanoj@nyassembly.gov Erik M. Dilan 518-455-5821 DilanE@nyassembly.gov Jeffrey Dinowitz 518-455-5965 DinowitzJ@nyassembly.gov Michael J. Fitzpatrick 518-455-5585 FitzpatrickM@nyassembly.gov Jodi Giglio 518-455-5294 giglioj2@nyassembly.gov Deborah J. Glick 518-455-4841 GlickD@nyassembly.gov Stephen Hawley 518-455-5811 HawleyS@nyassembly.gov Andrew Hevesi 518-455-4926 HevesiA@nyassembly.gov Pamela J. Hunter 518-455-4704 HunterP@nyassembly.gov Alicia Hyndman 518-455-4451 hyndmana@nyassembly.gov William B. Magnarelli 518-455-4826 MagnarW@nyassembly.gov Brian Manktelow 518-455-5655 manktelowb@nyassembly.gov John T. McDonald III 518-455-4474 McDonaldJ@nyassembly.gov Steven Otis 518-455-4897 OtisS@nyassembly.gov Phil Ramos 518-455-5185 ramosp@nyassembly.gov Nily Rozic 518-455-5172 RozicN@nyassembly.gov Rebecca A. Seawright 518-455-5676 SeawrightR@nyassembly.gov Amanda Septimo 518-455-5402 septimoa@nyassembly.gov Jo Anne Simon 518-455-5426 simonj@nyassembly.gov Matt Slater 518-455-5783 slaterm@nyassembly.gov Robert Smullen 518-455-5393 smullenr@nyassembly.gov Michaelle C. Solages 518-455-4465 SolagesM@nyassembly.gov Latrice M. Walker 518-455-4466 WalkerL@nyassembly.gov David I. Weprin 518-455-5806 WeprinD@nyassembly.gov Most important asks: “Hold A9156B in Ways & Means” and “Vote NO on A9156B.” New York Senate Bill 8925S8925A / A9156 — 7-Hydroxymitragynine RestrictionsNew York Senate Bill 8925 https://www.nysenate.gov/legislation/bills/2025/S8925 New York Kratom Bills Advance Through Committees as Advocacy Groups Mobilize Multiple kratom-related bills are currently moving through the New York legislature, with some proposals targeting kratom beverages, alkaloid limits, and highly concentrated products. Advocacy groups and consumers are now organizing opposition efforts as these bills continue advancing through committee review.Following is a review of bills in legislation currently, a link to 7Hopes website as they are organizing to fight these bills as well, and then a list of phone numbers and emails for New York senate, house, and assembly members that may impact these bills. The Most Important Bills Currently Moving S8925A / A9156 — 7-Hydroxymitragynine Restrictions This is currently one of the most active kratom-related bills in the New York legislature. The legislation would prohibit kratom products containing: Supporters describe the bill as a consumer safety measure targeting highly concentrated products, while critics argue the language could severely impact legal products already being sold in New York and create a pathway toward broader restrictions. Committee Timeline What Likely Happens Next The bill could: Because this bill has already undergone amendments and committee movement, many advocates consider it one of the highest priority bills to monitor. S8686 / A9114 — Kratom Food and Beverage Ban Another major proposal would prohibit the sale and manufacture of food or beverage products containing kratom, kratom derivatives, or 7-hydroxymitragynine. This bill has raised concerns among vendors and consumers because it could impact: Committee Timeline What Likely Happens Next The bill may: S10514 / A10969 — “Synthetic Kratom Kills Act” This newer proposal focuses heavily on synthetic or adulterated kratom products. The bill includes: Some advocates support portions related to testing and adulteration controls, while opposing broader restrictions that could affect traditional kratom products. Committee Timeline What Likely Happens Next The bill will likely: Existing New York Kratom Law New York has already enacted: Those measures were signed into law previously and are already in effect. Why We Are Mobilizing We argue that – Right now 7Hope is organizing to make an in person appearance to fight these proposed bills, if you are in the area and interested in participating here is a link to their website. Individuals interested in participating in New York advocacy efforts can learn more through 7 HOPE Alliance: Highest priority S8925A co-sponsors / related Senate targets Senate Consumer Protection Committee Senate Health Committee Assembly Codes Committee Assembly Health Committee emails

advocacy, Uncategorized

Draft regulations

I think its nigh time we stop fighting these bans and start asking for regulations that protect our access and also protect consumers from shady businesses. The main reason we have seen people being pushed towards these bans is two fold. Lack of public educationPoor perception created by unregulated businesses We can come together and show the public and our representatives that we are a real industry akin to medical and recreational cannabis by showing them that businesses can operate under normal regulations that any consumer product would. This is just a rough outline of what we could ask for, but moving forwards we can at least say “Instead of banning it, lets regulate it. Here is a list of regulations that would protect consumers and help generate tax revenue and more jobs, while allowing people to use the products for their beneficial nature.”

advocacy

FLYERS (Petitions, Studies & Stories)

3 QR Codes each of: Main FDA ban Petition, Studies & Facts, and Stories → PDF DOWNLOAD Main petition QR Code; “What is 7-OH?” → PDF DOWNLOAD Florida ban petition QR Code → PDF DOWNLOAD Haven Access Website QR Code → PDF DOWNLOAD

advocacy

Petitions

Main petition to stop the FDA recommended 7-OH scheduling: https://chng.it/5FNVKYff6v Petition to reverse the Florida emergency scheduling ban: https://chng.it/GZxpvC5q2Q AKA transparency petition: https://chng.it/YbF9Pvw6T4

advocacy

You can demand safety studies on 7-OH instead of bans right now!

NIDA (the National Institute on Drug Abuse) **helps influence DEA policy. **Right now you can send them a comment asking for: • Formal safety/toxicity studies on 7-OH• A non-biased evaluation before any scheduling• An end to corporate influence over natural compounds• You oppose scheduling 7-OH without proper human safety studies• NIDA should be funding research — not banning promising alkaloids• We need harm reduction tools, not criminalization 📝 Send your comment here:👉 https://nida.nih.gov/about-nida/contact-us/submit-question-comment 📚 Cite these studies:

advocacy

FDA/HHS/RFK CONTACTS

CONTACT INFO TO PROTECT 7-OHSend emails. Make calls. Every voice counts. ⸻ 📧 EMAIL TARGETS• commissioner@fda.hhs.gov (FDA Commissioner)• ash@hhs.gov (Secretary RFK Jr.’s Office – Assistant Secretary for Health)• hhsinfo@hhs.gov (Main HHS inbox)• druginfo@fda.hhs.gov (FDA Drug Info – Public Inbox)• ODSP@fda.hhs.gov (Office of Dietary Supplement Programs)• OPE@who.eop.gov (White House Office of Public Engagement) ⸻ 📝 WHAT TO SAY IN YOUR EMAIL 📌 Choose one or both approaches: ✅ 1. Share your story.Explain how 7-OH has helped you or someone you care about — such as managing pain, avoiding opioids, reducing withdrawal, or improving quality of life. ✅ 2. Use clear facts.Include strong, truthful data like:• Over 500 million estimated doses of 7-OH have been used• Zero verified deaths or respiratory depression• It’s a harm reduction tool that deserves regulation, not criminalization Make it personal + keep it respectful. Even 3–4 sentences can have impact. ⸻ 📞 CALL TO FOLLOW UP FDA Commissioner’s Office:📞 1-888-INFO-FDA (1-888-463-6332) → press 1 → 1 → 2 CDER (Drug Center):📞 301-796-3400 ODSP (Supplements Office):📞 301-796-8460 ⸻ 📞 HIGH IMPACT CALLS HHS Main Line:📞 202-690-7000 FDA Main Line:📞 301-796-5000 White House Comments Line:📞 202-456-1111 ⸻ 🗣️ TALKING POINTS (FOR CALLS) 🗨️ “I’m calling to urge opposition to any restriction on 7-hydroxymitragynine. It has helped thousands and saved lives. We need regulation — not criminalization.” 🗨️ “Over 500 million doses. No deaths. This deserves fair evaluation, not fear-based scheduling.” 🗨️ “Please tell Secretary RFK Jr. that 7-OH is a powerful harm reduction tool. Don’t let the FDA ban a life-saving compound.”

advocacy

Government Representatives that may help our initiative.

Why contact: Liberty‑focused, strong opponent of federal overreach, and previously defended kratom policy choices as constitutional issues.  Best message hook: Emphasize civil liberties, government restraint, and harm reduction. ⸻ Why contact: Chair of Senate Energy & Natural Resources, skeptical of overregulation, and has questioned FDA/DEA actions previously. Best message hook: Focus on protecting medical freedom and preventing unnecessary federal bans. ⸻ Why contact: Powerful Finance Committee member and vocal on medical alternatives and drug policy reform.  Best message hook: State how scheduling threatens patient access and innovation in natural therapies. ⸻ Why contact: One of few House members supportive of kratom rights, open to harm reduction approaches.Best message hook: Emphasize continuity: 7‑OH is a safer alternative many of his constituents rely on. ⸻ Why contact: On House Energy & Commerce (Health subcommittee), familiar with nuanced regulatory policy.Best message hook: Stress risk of bypassing science and oversight — direct legislative influence can demand transparency. 🇺🇸 SEN. RAND PAUL🔗 https://www.paul.senate.gov/connect/📞 202-224-4343🧠 Why: Liberty advocate who opposes federal overreach✏️ Tip: Mention his history standing against prohibition and for individual freedoms 🇺🇸 SEN. MIKE LEE🔗 https://www.lee.senate.gov/contact📞 202-224-5444🧠 Why: Regulatory skeptic; key role on oversight committees✏️ Tip: Highlight his focus on due process, limited government, and transparency 🇺🇸 SEN. RON WYDEN🔗 https://www.wyden.senate.gov/contact/email-ron📞 202-224-5244🧠 Why: Senior member on Senate Finance, influences health policy✏️ Tip: Frame it as a need for fair access to alternatives and science-based policy 🇺🇸 REP. MARK POCAN (WI constituents only)🔗 https://pocan.house.gov/address_authentication?form=/contact/contact-my-team📞 202-225-2906🧠 Why: Publicly supported kratom and harm reduction before✏️ Tip: Mention his past advocacy and ask him to oppose bans lacking human data 🇺🇸 REP. MORGAN GRIFFITH🔗 https://morgangriffith.house.gov/contact/contactform.htm📞 202-225-3861🧠 Why: Sits on House Energy & Commerce Health Subcommittee✏️ Tip: Emphasize the need for scientific evidence and measured regulation

advocacy

Contact these DEA offices to help stop or delay the scheduling of 7OH:

Contact these DEA offices to help stop or delay the scheduling of 7OH: ⸻ DEA HeadquartersPhone: (571) 362-8487Main Phone: (202) 307-1000Use for general questions about DEA processes. Ask for clear timelines and urge them to delay scheduling until thorough scientific review and public input can be fully considered. Emphasize the importance of harm reduction and the potential consequences of rushing the decision. ⸻ DEA Public AffairsEmail: DEA.Public.Affairs@dea.govPhone: (571) 776-2508Ask about public education plans on 7-OH and how the DEA will communicate the scheduling process. Urge transparency and encourage them to consider community concerns and harm reduction before proceeding. Request that scheduling be delayed to allow more open dialogue. ⸻ Office of Public Affairs, Community Outreach SectionPhone: (202) 307-7936Email: community.outreach@dea.govContact regarding community concerns and outreach related to 7-OH and kratom. Encourage them to raise public awareness about potential risks of scheduling and ask for a delay to gather more data and input. ⸻ Office of Diversion Control (Diversion Control Division)Phone: 202-307-7297Emails: ODLL@dea.gov, DPY@dea.govThis division regulates controlled substances to prevent illegal diversion. Since 7-OH scheduling would create a ban, ask how they plan to handle the likely rise of an illegal black market and associated public health risks. Urge them to delay scheduling until they have evaluated and prepared to mitigate these risks thoroughly. ⸻ Registration QuestionsEmail: DEA.Registration.Help@dea.govCurrently less relevant since 7-OH isn’t scheduled yet; focus on preventing scheduling before registration becomes an issue. If contacted, emphasize the need to halt or delay scheduling for more research. ⸻Press InquiriesEmail: DEAPress@dea.govPhone (voicemail): 571-776-2508 Media can use this to get official DEA statements. Encourage journalists covering the scheduling fight to highlight community concerns, the lack of toxicity data, and the need for delays to ensure safety and fairness. ⸻ How to help:@everyone can call or email these contacts with polite but firm messages urging them to reconsider or delay scheduling 7-OH. Emphasize: • Harm reduction benefits of 7-OH • Lack of evidence for toxicity or public emergency • Broad community support and scientific studies • Risks of creating illegal black markets and public health issues • The need for transparency and thorough review before scheduling

Scroll to Top